fanta.bio Sample: CNhs11842
21078 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1025 / 10929 (9.4%) | 306 / 109290 (0.3%) | −324.0 | −324.0 | 33.50 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 450 / 10929 (4.1%) | 144 / 109290 (0.1%) | −324.0 | −324.0 | 31.25 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1546 / 10929 (14.1%) | 507 / 109290 (0.5%) | −324.0 | −324.0 | 30.49 |
| SCML2 SRX644728 | 293 Kidney | 1357 / 10929 (12.4%) | 469 / 109290 (0.4%) | −324.0 | −324.0 | 28.93 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2107 / 10929 (19.3%) | 779 / 109290 (0.7%) | −324.0 | −324.0 | 27.05 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1438 / 10929 (13.2%) | 534 / 109290 (0.5%) | −324.0 | −324.0 | 26.93 |
| HIF1A SRX11007095 | HK-2 Kidney | 1799 / 10929 (16.5%) | 678 / 109290 (0.6%) | −324.0 | −324.0 | 26.53 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2052 / 10929 (18.8%) | 777 / 109290 (0.7%) | −324.0 | −324.0 | 26.41 |
| FOXP1 SRX736067 | LNCAP Prostate | 1908 / 10929 (17.5%) | 729 / 109290 (0.7%) | −324.0 | −324.0 | 26.17 |
| TP53 SRX19538279 | Osteoblasts Bone | 469 / 10929 (4.3%) | 198 / 109290 (0.2%) | −324.0 | −324.0 | 23.69 |
| MYH11 SRX265221 | ME-1 Blood | 836 / 10929 (7.6%) | 413 / 109290 (0.4%) | −324.0 | −324.0 | 20.24 |
| MED1 SRX9419944 | BT-474 Breast | 2638 / 10929 (24.1%) | 1962 / 109290 (1.8%) | −324.0 | −324.0 | 13.45 |
| MED1 SRX9419945 | BT-474 Breast | 2696 / 10929 (24.7%) | 2017 / 109290 (1.8%) | −324.0 | −324.0 | 13.37 |
| BRD4 SRX9419937 | BT-474 Breast | 2625 / 10929 (24.0%) | 2022 / 109290 (1.9%) | −324.0 | −324.0 | 12.98 |
| MED1 SRX9419946 | BT-474 Breast | 2723 / 10929 (24.9%) | 2099 / 109290 (1.9%) | −324.0 | −324.0 | 12.97 |
| BRD4 SRX9419935 | BT-474 Breast | 2602 / 10929 (23.8%) | 2021 / 109290 (1.8%) | −324.0 | −324.0 | 12.87 |
| BRD4 SRX9419936 | BT-474 Breast | 2697 / 10929 (24.7%) | 2108 / 109290 (1.9%) | −324.0 | −324.0 | 12.79 |
| MED1 SRX9419947 | BT-474 Breast | 2642 / 10929 (24.2%) | 2072 / 109290 (1.9%) | −324.0 | −324.0 | 12.75 |
| BRD4 SRX9419938 | BT-474 Breast | 2684 / 10929 (24.6%) | 2105 / 109290 (1.9%) | −324.0 | −324.0 | 12.75 |
| EZH2 SRX2146136 | LNCAP Prostate | 6112 / 10929 (55.9%) | 5622 / 109290 (5.1%) | −324.0 | −324.0 | 10.87 |
| BRD4 SRX736201 | 90-8TL Neural | 4648 / 10929 (42.5%) | 4555 / 109290 (4.2%) | −324.0 | −324.0 | 10.20 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1561 / 10929 (14.3%) | 1799 / 109290 (1.6%) | −324.0 | −324.0 | 8.68 |
| HIF1A SRX20663235 | HK-2 Kidney | 434 / 10929 (4.0%) | 193 / 109290 (0.2%) | −296.4 | −293.3 | 22.49 |
| TP53 SRX19538268 | U2OS Bone | 385 / 10929 (3.5%) | 121 / 109290 (0.1%) | −289.0 | −285.8 | 31.82 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 581 / 10929 (5.3%) | 587 / 109290 (0.5%) | −284.4 | −281.2 | 9.90 |
| TP53 SRX19538274 | U2OS Bone | 381 / 10929 (3.5%) | 132 / 109290 (0.1%) | −279.0 | −275.9 | 28.86 |
| TP53 SRX19538276 | U2OS Bone | 375 / 10929 (3.4%) | 136 / 109290 (0.1%) | −271.3 | −268.3 | 27.57 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1031 / 10929 (9.4%) | 2466 / 109290 (2.3%) | −268.2 | −265.1 | 4.18 |
| TP53 SRX19538273 | U2OS Bone | 351 / 10929 (3.2%) | 106 / 109290 (0.1%) | −265.9 | −262.8 | 33.11 |
| TP53 SRX19538267 | U2OS Bone | 351 / 10929 (3.2%) | 109 / 109290 (0.1%) | −264.1 | −261.1 | 32.20 |
| TP53 SRX19538280 | Osteoblasts Bone | 374 / 10929 (3.4%) | 152 / 109290 (0.1%) | −262.2 | −259.1 | 24.61 |
| TP53 SRX19538275 | U2OS Bone | 348 / 10929 (3.2%) | 119 / 109290 (0.1%) | −255.6 | −252.6 | 29.24 |
| TP53 SRX19538281 | Osteoblasts Bone | 391 / 10929 (3.6%) | 205 / 109290 (0.2%) | −253.0 | −250.0 | 19.07 |
| TP53 SRX19538269 | U2OS Bone | 409 / 10929 (3.7%) | 277 / 109290 (0.3%) | −240.6 | −237.6 | 14.77 |
| AR SRX10820653 | LNCAP Prostate | 343 / 10929 (3.1%) | 140 / 109290 (0.1%) | −240.1 | −237.1 | 24.50 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 753 / 10929 (6.9%) | 1485 / 109290 (1.4%) | −233.4 | −230.4 | 5.07 |
| BRD4 SRX736204 | 90-8TL Neural | 840 / 10929 (7.7%) | 1871 / 109290 (1.7%) | −233.1 | −230.2 | 4.49 |
| KAT7 SRX101303 | RKO Digestive tract | 1119 / 10929 (10.2%) | 3322 / 109290 (3.0%) | −227.6 | −224.7 | 3.37 |
| BRD1 SRX286203 | RKO Digestive tract | 965 / 10929 (8.8%) | 2675 / 109290 (2.4%) | −212.3 | −209.4 | 3.61 |
| TP53 SRX19538270 | U2OS Bone | 375 / 10929 (3.4%) | 280 / 109290 (0.3%) | −211.6 | −208.7 | 13.39 |
| BRPF3 SRX796084 | RKO Digestive tract | 1198 / 10929 (11.0%) | 3988 / 109290 (3.6%) | −209.3 | −206.4 | 3.00 |
| TP53 SRX19538282 | Osteoblasts Bone | 341 / 10929 (3.1%) | 208 / 109290 (0.2%) | −208.8 | −205.9 | 16.39 |
| AR SRX10820651 | LNCAP Prostate | 345 / 10929 (3.2%) | 217 / 109290 (0.2%) | −208.8 | −205.9 | 15.90 |
| AGO2 SRX4708039 | Hep G2 Liver | 1335 / 10929 (12.2%) | 4856 / 109290 (4.4%) | −205.3 | −202.4 | 2.75 |
| Epitope tags SRX10549776 | K-562 Blood | 1079 / 10929 (9.9%) | 3376 / 109290 (3.1%) | −204.5 | −201.6 | 3.20 |
| TP53 SRX19538271 | U2OS Bone | 521 / 10929 (4.8%) | 788 / 109290 (0.7%) | −198.2 | −195.4 | 6.61 |
| PBX4 SRX2731658 | PC-3 Prostate | 667 / 10929 (6.1%) | 17298 / 109290 (15.8%) | −197.0 | −194.1 | 0.39 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 475 / 10929 (4.3%) | 655 / 109290 (0.6%) | −192.5 | −189.7 | 7.25 |
| IRF3 SRX11453858 | Hep G2 Liver | 247 / 10929 (2.3%) | 71 / 109290 (0.1%) | −189.1 | −186.3 | 34.79 |
| BRPF3 SRX796086 | RKO Digestive tract | 1118 / 10929 (10.2%) | 3804 / 109290 (3.5%) | −188.5 | −185.7 | 2.94 |
| BRPF3 SRX796085 | RKO Digestive tract | 849 / 10929 (7.8%) | 2340 / 109290 (2.1%) | −187.2 | −184.4 | 3.63 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 918 / 10929 (8.4%) | 2720 / 109290 (2.5%) | −185.6 | −182.8 | 3.38 |
| ING5 SRX286202 | RKO Digestive tract | 1025 / 10929 (9.4%) | 3334 / 109290 (3.1%) | −183.5 | −180.7 | 3.07 |
| BMI1 SRX644729 | 293 Kidney | 246 / 10929 (2.3%) | 82 / 109290 (0.1%) | −181.8 | −179.0 | 30.00 |
| IRF3 SRX11453861 | Hep G2 Liver | 225 / 10929 (2.1%) | 66 / 109290 (0.1%) | −171.5 | −168.7 | 34.09 |
| ESR1 SRX7624157 | MCF-7 Breast | 482 / 10929 (4.4%) | 13395 / 109290 (12.3%) | −163.4 | −160.6 | 0.36 |
| ESR1 SRX7624156 | MCF-7 Breast | 277 / 10929 (2.5%) | 10088 / 109290 (9.2%) | −163.2 | −160.4 | 0.27 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 984 / 10929 (9.0%) | 3393 / 109290 (3.1%) | −161.7 | −158.9 | 2.90 |
| ESR1 SRX4367193 | MCF-7 Breast | 619 / 10929 (5.7%) | 15324 / 109290 (14.0%) | −160.3 | −157.6 | 0.40 |
| ESR1 SRX20282961 | MCF-7 Breast | 209 / 10929 (1.9%) | 8772 / 109290 (8.0%) | −159.5 | −156.7 | 0.24 |
| ESR1 SRX371469 | MCF-7 Breast | 166 / 10929 (1.5%) | 7905 / 109290 (7.2%) | −157.2 | −154.5 | 0.21 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 222 / 10929 (2.0%) | 87 / 109290 (0.1%) | −157.1 | −154.4 | 25.52 |
| ESR1 SRX371478 | MCF-7 Breast | 223 / 10929 (2.0%) | 8902 / 109290 (8.1%) | −155.4 | −152.7 | 0.25 |
| STAT5B SRX831881 | CD8+ T cells Blood | 226 / 10929 (2.1%) | 101 / 109290 (0.1%) | −153.9 | −151.2 | 22.38 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 432 / 10929 (4.0%) | 713 / 109290 (0.7%) | −153.8 | −151.1 | 6.06 |
| FOXA1 SRX176862 | MCF-7 Breast | 235 / 10929 (2.2%) | 9060 / 109290 (8.3%) | −153.5 | −150.8 | 0.26 |
| Epitope tags SRX10549778 | K-562 Blood | 841 / 10929 (7.7%) | 2691 / 109290 (2.5%) | −153.0 | −150.4 | 3.13 |
| FOXA1 SRX371481 | MCF-7 Breast | 179 / 10929 (1.6%) | 7989 / 109290 (7.3%) | −151.6 | −149.0 | 0.22 |
| FOXA1 SRX4815198 | MCF-7 Breast | 677 / 10929 (6.2%) | 15838 / 109290 (14.5%) | −151.6 | −148.9 | 0.43 |
| FOXA1 SRX176863 | MCF-7 Breast | 215 / 10929 (2.0%) | 8614 / 109290 (7.9%) | −150.4 | −147.7 | 0.25 |
| ESR1 SRX20282960 | MCF-7 Breast | 200 / 10929 (1.8%) | 8325 / 109290 (7.6%) | −150.0 | −147.3 | 0.24 |
| ESR1 SRX176860 | MCF-7 Breast | 307 / 10929 (2.8%) | 10171 / 109290 (9.3%) | −149.6 | −146.9 | 0.30 |
| FOXA1 SRX4815197 | MCF-7 Breast | 483 / 10929 (4.4%) | 12908 / 109290 (11.8%) | −148.7 | −146.0 | 0.37 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 208 / 10929 (1.9%) | 8412 / 109290 (7.7%) | −147.9 | −145.3 | 0.25 |
| MEAF6 DRX234811 | 293 Kidney | 1182 / 10929 (10.8%) | 4831 / 109290 (4.4%) | −147.7 | −145.1 | 2.45 |
| NFYB SRX16608147 | HeLa Uterus | 232 / 10929 (2.1%) | 128 / 109290 (0.1%) | −147.4 | −144.7 | 18.13 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 212 / 10929 (1.9%) | 8461 / 109290 (7.7%) | −147.2 | −144.6 | 0.25 |
| ESR1 SRX176861 | MCF-7 Breast | 312 / 10929 (2.9%) | 10174 / 109290 (9.3%) | −147.2 | −144.5 | 0.31 |
| TP53 SRX19538272 | U2OS Bone | 425 / 10929 (3.9%) | 728 / 109290 (0.7%) | −146.9 | −144.3 | 5.84 |
| AGO2 SRX6783958 | Hep G2 Liver | 856 / 10929 (7.8%) | 2858 / 109290 (2.6%) | −146.6 | −144.0 | 3.00 |
| ESR1 SRX371479 | MCF-7 Breast | 154 / 10929 (1.4%) | 7362 / 109290 (6.7%) | −146.4 | −143.8 | 0.21 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 460 / 10929 (4.2%) | 882 / 109290 (0.8%) | −145.0 | −142.4 | 5.22 |
| CDK9 SRX7366783 | MCF-7 Breast | 208 / 10929 (1.9%) | 87 / 109290 (0.1%) | −144.5 | −141.9 | 23.91 |
| LEO1 SRX1873456 | SEM Blood | 1038 / 10929 (9.5%) | 3984 / 109290 (3.6%) | −144.0 | −141.4 | 2.61 |
| ESR1 SRX371467 | MCF-7 Breast | 188 / 10929 (1.7%) | 7891 / 109290 (7.2%) | −142.7 | −140.1 | 0.24 |
| ESR1 SRX20282939 | MCF-7 Breast | 214 / 10929 (2.0%) | 8309 / 109290 (7.6%) | −141.0 | −138.4 | 0.26 |
| GATA3 SRX190239 | MCF-7 Breast | 289 / 10929 (2.6%) | 9589 / 109290 (8.8%) | −140.9 | −138.3 | 0.30 |
| ETS1 SRX3033231 | HEYA8 Gonad | 255 / 10929 (2.3%) | 200 / 109290 (0.2%) | −140.7 | −138.1 | 12.75 |
| CDK9 SRX7366781 | MCF-7 Breast | 200 / 10929 (1.8%) | 81 / 109290 (0.1%) | −140.3 | −137.7 | 24.69 |
| SSRP1 SRX3436567 | HT-1080 Bone | 309 / 10929 (2.8%) | 355 / 109290 (0.3%) | −140.1 | −137.5 | 8.70 |
| MEAF6 DRX300417 | 293 Kidney | 1076 / 10929 (9.8%) | 4292 / 109290 (3.9%) | −139.8 | −137.2 | 2.51 |
| AGO2 SRX6783957 | Hep G2 Liver | 851 / 10929 (7.8%) | 2926 / 109290 (2.7%) | −139.7 | −137.1 | 2.91 |
| ESR1 SRX371476 | MCF-7 Breast | 124 / 10929 (1.1%) | 6556 / 109290 (6.0%) | −138.8 | −136.3 | 0.19 |
| ESR1 SRX1531791 | MCF-7 Breast | 175 / 10929 (1.6%) | 7527 / 109290 (6.9%) | −138.5 | −136.0 | 0.23 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 285 / 10929 (2.6%) | 9447 / 109290 (8.6%) | −138.5 | −135.9 | 0.30 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 278 / 10929 (2.5%) | 9320 / 109290 (8.5%) | −138.2 | −135.7 | 0.30 |
| FOXA1 SRX371482 | MCF-7 Breast | 292 / 10929 (2.7%) | 9533 / 109290 (8.7%) | −137.6 | −135.1 | 0.31 |
| FOXA1 SRX371483 | MCF-7 Breast | 219 / 10929 (2.0%) | 8291 / 109290 (7.6%) | −137.6 | −135.0 | 0.26 |
| ESR1 SRX20282972 | MCF-7 Breast | 214 / 10929 (2.0%) | 8182 / 109290 (7.5%) | −136.9 | −134.4 | 0.26 |
| TP53 SRX396254 | Fibroblasts Others | 641 / 10929 (5.9%) | 1804 / 109290 (1.7%) | −136.9 | −134.3 | 3.55 |
| ESR1 SRX194569 | MCF-7 Breast | 196 / 10929 (1.8%) | 7852 / 109290 (7.2%) | −136.5 | −134.0 | 0.25 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 344 / 10929 (3.1%) | 10318 / 109290 (9.4%) | −135.8 | −133.2 | 0.33 |
| Epitope tags DRX443510 | 293 Kidney | 1020 / 10929 (9.3%) | 4008 / 109290 (3.7%) | −135.7 | −133.2 | 2.54 |
| ESR1 SRX20282954 | MCF-7 Breast | 207 / 10929 (1.9%) | 8012 / 109290 (7.3%) | −135.3 | −132.8 | 0.26 |
| FOXA1 SRX1161177 | MCF-7 Breast | 198 / 10929 (1.8%) | 7826 / 109290 (7.2%) | −134.6 | −132.1 | 0.25 |
| FOXA1 SRX371480 | MCF-7 Breast | 115 / 10929 (1.1%) | 6246 / 109290 (5.7%) | −134.3 | −131.8 | 0.18 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 387 / 10929 (3.5%) | 660 / 109290 (0.6%) | −134.2 | −131.7 | 5.86 |
| ESR1 SRX371471 | ZR-75-1 Breast | 212 / 10929 (1.9%) | 8047 / 109290 (7.4%) | −133.7 | −131.2 | 0.26 |
| FOXA1 SRX3931044 | MCF-7 Breast | 454 / 10929 (4.2%) | 11941 / 109290 (10.9%) | −133.6 | −131.1 | 0.38 |
| AR SRX1067071 | LHSAR Prostate | 410 / 10929 (3.8%) | 11273 / 109290 (10.3%) | −133.5 | −131.0 | 0.36 |
| FOS SRX150477 | MCF 10A Breast | 508 / 10929 (4.6%) | 12729 / 109290 (11.6%) | −133.2 | −130.7 | 0.40 |
| ESR1 SRX10365536 | MCF-7 Breast | 79 / 10929 (0.7%) | 5454 / 109290 (5.0%) | −133.2 | −130.7 | 0.14 |
| AR SRX1067070 | LHSAR Prostate | 517 / 10929 (4.7%) | 12810 / 109290 (11.7%) | −131.8 | −129.4 | 0.40 |
| ESR1 SRX371470 | ZR-75-1 Breast | 175 / 10929 (1.6%) | 7312 / 109290 (6.7%) | −131.3 | −128.8 | 0.24 |
| ESR1 SRX10365535 | MCF-7 Breast | 146 / 10929 (1.3%) | 6747 / 109290 (6.2%) | −130.5 | −128.0 | 0.22 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 450 / 10929 (4.1%) | 949 / 109290 (0.9%) | −130.1 | −127.7 | 4.74 |
| EP300 ERX626811 | U-937 Blood | 869 / 10929 (8.0%) | 3190 / 109290 (2.9%) | −128.8 | −126.3 | 2.72 |
| TLE3 SRX4815191 | MCF-7 Breast | 195 / 10929 (1.8%) | 7581 / 109290 (6.9%) | −128.2 | −125.8 | 0.26 |
| STAT1 SRX23678708 | K-562 Blood | 1057 / 10929 (9.7%) | 4374 / 109290 (4.0%) | −128.2 | −125.8 | 2.42 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 263 / 10929 (2.4%) | 8740 / 109290 (8.0%) | −127.9 | −125.5 | 0.30 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 156 / 10929 (1.4%) | 6854 / 109290 (6.3%) | −127.8 | −125.4 | 0.23 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 390 / 10929 (3.6%) | 715 / 109290 (0.7%) | −127.5 | −125.1 | 5.45 |
| ESR1 SRX20282955 | MCF-7 Breast | 205 / 10929 (1.9%) | 7729 / 109290 (7.1%) | −127.3 | −124.8 | 0.27 |
| RBFOX2 SRX4708082 | K-562 Blood | 1597 / 10929 (14.6%) | 8132 / 109290 (7.4%) | −127.0 | −124.6 | 1.96 |
| ESR1 SRX371468 | MCF-7 Breast | 115 / 10929 (1.1%) | 6021 / 109290 (5.5%) | −126.3 | −123.9 | 0.19 |
| EP300 ERX626821 | U-937 Blood | 859 / 10929 (7.9%) | 3168 / 109290 (2.9%) | −126.3 | −123.9 | 2.71 |
| YAP1 SRX757325 | H2052 Lung | 556 / 10929 (5.1%) | 13168 / 109290 (12.0%) | −126.2 | −123.8 | 0.42 |
| ESR1 SRX2881002 | MCF-7 Breast | 183 / 10929 (1.7%) | 7281 / 109290 (6.7%) | −125.5 | −123.0 | 0.25 |
| GATA3 SRX5057632 | MCF-7 Breast | 119 / 10929 (1.1%) | 6067 / 109290 (5.6%) | −125.3 | −122.8 | 0.20 |
| FOXA1 SRX1161176 | MCF-7 Breast | 194 / 10929 (1.8%) | 7467 / 109290 (6.8%) | −125.2 | −122.7 | 0.26 |
| YAP1 SRX5718140 | 293 Kidney | 360 / 10929 (3.3%) | 10206 / 109290 (9.3%) | −125.0 | −122.6 | 0.35 |
| ESR1 SRX20282973 | MCF-7 Breast | 246 / 10929 (2.3%) | 8350 / 109290 (7.6%) | −124.7 | −122.3 | 0.29 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 616 / 10929 (5.6%) | 1815 / 109290 (1.7%) | −124.1 | −121.7 | 3.39 |
| MLLT6 DRX059637 | 293 Kidney | 305 / 10929 (2.8%) | 419 / 109290 (0.4%) | −123.7 | −121.3 | 7.28 |
| GATA3 SRX176864 | MCF-7 Breast | 146 / 10929 (1.3%) | 6529 / 109290 (6.0%) | −123.2 | −120.8 | 0.22 |
| ESR1 SRX371477 | MCF-7 Breast | 81 / 10929 (0.7%) | 5210 / 109290 (4.8%) | −122.7 | −120.3 | 0.16 |
| ESR1 SRX4367192 | MCF-7 Breast | 443 / 10929 (4.1%) | 11345 / 109290 (10.4%) | −121.6 | −119.2 | 0.39 |
| FOS SRX150478 | MCF 10A Breast | 565 / 10929 (5.2%) | 13105 / 109290 (12.0%) | −121.1 | −118.7 | 0.43 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 158 / 10929 (1.4%) | 6689 / 109290 (6.1%) | −121.1 | −118.7 | 0.24 |
| FOXA1 SRX1161173 | MCF-7 Breast | 164 / 10929 (1.5%) | 6795 / 109290 (6.2%) | −120.9 | −118.6 | 0.24 |
| FOXA1 SRX1161175 | MCF-7 Breast | 152 / 10929 (1.4%) | 6565 / 109290 (6.0%) | −120.6 | −118.2 | 0.23 |
| ESR1 SRX2881000 | MCF-7 Breast | 174 / 10929 (1.6%) | 6970 / 109290 (6.4%) | −120.6 | −118.2 | 0.25 |
| ESR1 SRX194572 | MCF-7 Breast | 122 / 10929 (1.1%) | 5992 / 109290 (5.5%) | −120.5 | −118.1 | 0.20 |
| ESR1 SRX3110725 | MCF-7 Breast | 176 / 10929 (1.6%) | 7002 / 109290 (6.4%) | −120.4 | −118.1 | 0.25 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 209 / 10929 (1.9%) | 7577 / 109290 (6.9%) | −120.3 | −117.9 | 0.28 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 316 / 10929 (2.9%) | 477 / 109290 (0.4%) | −120.0 | −117.7 | 6.62 |
| ESR1 SRX20282940 | MCF-7 Breast | 228 / 10929 (2.1%) | 7893 / 109290 (7.2%) | −119.9 | −117.5 | 0.29 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 508 / 10929 (4.6%) | 12215 / 109290 (11.2%) | −119.3 | −116.9 | 0.42 |
| RAC1 SRX10365543 | MCF-7 Breast | 97 / 10929 (0.9%) | 5430 / 109290 (5.0%) | −118.5 | −116.1 | 0.18 |
| ESR1 SRX330067 | MCF-7 Breast | 184 / 10929 (1.7%) | 7043 / 109290 (6.4%) | −117.2 | −114.8 | 0.26 |
| RAC1 SRX10365541 | MCF-7 Breast | 100 / 10929 (0.9%) | 5453 / 109290 (5.0%) | −117.1 | −114.8 | 0.18 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 1030 / 10929 (9.4%) | 4409 / 109290 (4.0%) | −117.0 | −114.7 | 2.34 |
| ARID1A SRX5089376 | MCF-7 Breast | 178 / 10929 (1.6%) | 6919 / 109290 (6.3%) | −116.6 | −114.3 | 0.26 |
| YAP1 SRX757326 | H2052 Lung | 484 / 10929 (4.4%) | 11767 / 109290 (10.8%) | −116.5 | −114.2 | 0.41 |
| STAT1 SRX23678707 | K-562 Blood | 964 / 10929 (8.8%) | 3988 / 109290 (3.6%) | −116.5 | −114.2 | 2.42 |
| ESR1 SRX371475 | BT-474 Breast | 91 / 10929 (0.8%) | 5237 / 109290 (4.8%) | −116.1 | −113.8 | 0.17 |
| ESR1 SRX20282971 | MCF-7 Breast | 207 / 10929 (1.9%) | 7413 / 109290 (6.8%) | −116.1 | −113.8 | 0.28 |
| ESR1 SRX2943591 | MCF-7 Breast | 139 / 10929 (1.3%) | 6182 / 109290 (5.7%) | −116.0 | −113.6 | 0.22 |
| TLE3 SRX4815192 | MCF-7 Breast | 186 / 10929 (1.7%) | 7026 / 109290 (6.4%) | −115.6 | −113.3 | 0.26 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 211 / 10929 (1.9%) | 7456 / 109290 (6.8%) | −115.4 | −113.1 | 0.28 |
| ESR1 SRX20282953 | MCF-7 Breast | 166 / 10929 (1.5%) | 6661 / 109290 (6.1%) | −115.2 | −112.9 | 0.25 |
| ESR1 SRX20282946 | MCF-7 Breast | 115 / 10929 (1.1%) | 5697 / 109290 (5.2%) | −115.2 | −112.9 | 0.20 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 554 / 10929 (5.1%) | 1597 / 109290 (1.5%) | −114.6 | −112.2 | 3.47 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 194 / 10929 (1.8%) | 7119 / 109290 (6.5%) | −114.0 | −111.7 | 0.27 |
| FOXA1 SRX11222441 | MCF-7 Breast | 162 / 10929 (1.5%) | 6540 / 109290 (6.0%) | −113.7 | −111.4 | 0.25 |
| ESR1 SRX330069 | MCF-7 Breast | 119 / 10929 (1.1%) | 5732 / 109290 (5.2%) | −113.7 | −111.4 | 0.21 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 202 / 10929 (1.8%) | 7242 / 109290 (6.6%) | −113.5 | −111.2 | 0.28 |
| MEN1 SRX11712604 | K-562 Blood | 948 / 10929 (8.7%) | 3941 / 109290 (3.6%) | −113.4 | −111.1 | 2.41 |
| FOXA1 SRX11222437 | MCF-7 Breast | 149 / 10929 (1.4%) | 6286 / 109290 (5.8%) | −113.2 | −110.9 | 0.24 |
| ESR1 SRX20282959 | MCF-7 Breast | 73 / 10929 (0.7%) | 4753 / 109290 (4.3%) | −112.5 | −110.2 | 0.15 |
| FOXA1 SRX100454 | T-47D Breast | 291 / 10929 (2.7%) | 8685 / 109290 (7.9%) | −112.5 | −110.2 | 0.34 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 93 / 10929 (0.9%) | 5169 / 109290 (4.7%) | −112.2 | −109.9 | 0.18 |
| ING2 SRX286201 | RKO Digestive tract | 937 / 10929 (8.6%) | 3895 / 109290 (3.6%) | −112.1 | −109.8 | 2.41 |
| ESR1 SRX371474 | BT-474 Breast | 86 / 10929 (0.8%) | 5022 / 109290 (4.6%) | −112.0 | −109.7 | 0.17 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 205 / 10929 (1.9%) | 7245 / 109290 (6.6%) | −112.0 | −109.7 | 0.28 |
| FOXA1 SRX1787653 | MCF-7 Breast | 176 / 10929 (1.6%) | 6740 / 109290 (6.2%) | −111.9 | −109.6 | 0.26 |
| ESR1 SRX330070 | MCF-7 Breast | 99 / 10929 (0.9%) | 5272 / 109290 (4.8%) | −111.5 | −109.3 | 0.19 |
| ESR1 SRX20282938 | MCF-7 Breast | 168 / 10929 (1.5%) | 6568 / 109290 (6.0%) | −111.0 | −108.8 | 0.26 |
| RBFOX2 SRX3322782 | K-562 Blood | 1252 / 10929 (11.5%) | 6045 / 109290 (5.5%) | −111.0 | −108.8 | 2.07 |
| FOXA1 SRX11222442 | MCF-7 Breast | 140 / 10929 (1.3%) | 6054 / 109290 (5.5%) | −111.0 | −108.7 | 0.23 |
| PGR SRX1012655 | MCF-7 Breast | 128 / 10929 (1.2%) | 5821 / 109290 (5.3%) | −110.8 | −108.5 | 0.22 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 728 / 10929 (6.7%) | 2621 / 109290 (2.4%) | −110.8 | −108.5 | 2.78 |
| SSRP1 SRX3436566 | HT-1080 Bone | 225 / 10929 (2.1%) | 226 / 109290 (0.2%) | −110.0 | −107.8 | 9.96 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 516 / 10929 (4.7%) | 11975 / 109290 (11.0%) | −110.0 | −107.7 | 0.43 |
| KAT6A SRX20971022 | Fibroblasts Others | 166 / 10929 (1.5%) | 82 / 109290 (0.1%) | −109.6 | −107.4 | 20.24 |
| ESR1 SRX1012629 | MCF-7 Breast | 128 / 10929 (1.2%) | 5779 / 109290 (5.3%) | −109.4 | −107.2 | 0.22 |
| FOXA1 SRX1161174 | MCF-7 Breast | 237 / 10929 (2.2%) | 7700 / 109290 (7.0%) | −109.3 | −107.0 | 0.31 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 212 / 10929 (1.9%) | 7280 / 109290 (6.7%) | −109.2 | −107.0 | 0.29 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 205 / 10929 (1.9%) | 7150 / 109290 (6.5%) | −109.1 | −106.8 | 0.29 |
| AR SRX9469988 | LAPC-4 Prostate | 301 / 10929 (2.8%) | 8723 / 109290 (8.0%) | −109.0 | −106.7 | 0.35 |
| ESR1 SRX10365532 | MCF-7 Breast | 109 / 10929 (1.0%) | 5394 / 109290 (4.9%) | −108.8 | −106.6 | 0.20 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 500 / 10929 (4.6%) | 1382 / 109290 (1.3%) | −108.7 | −106.5 | 3.62 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 578 / 10929 (5.3%) | 12796 / 109290 (11.7%) | −108.6 | −106.4 | 0.45 |
| FOXA1 SRX1787652 | MCF-7 Breast | 125 / 10929 (1.1%) | 5677 / 109290 (5.2%) | −107.8 | −105.6 | 0.22 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 179 / 10929 (1.6%) | 6655 / 109290 (6.1%) | −107.7 | −105.4 | 0.27 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 921 / 10929 (8.4%) | 3875 / 109290 (3.5%) | −107.6 | −105.4 | 2.38 |
| SS18 SRX3468047 | Fibroblasts Others | 590 / 10929 (5.4%) | 12923 / 109290 (11.8%) | −107.6 | −105.4 | 0.46 |
| FOXA1 SRX3923514 | MCF-7 Breast | 236 / 10929 (2.2%) | 7615 / 109290 (7.0%) | −107.2 | −104.9 | 0.31 |
| JADE3 DRX300415 | 293 Kidney | 994 / 10929 (9.1%) | 4363 / 109290 (4.0%) | −107.1 | −104.9 | 2.28 |
| SETD1A SRX23734379 | MOLM-13 Blood | 815 / 10929 (7.5%) | 3212 / 109290 (2.9%) | −106.9 | −104.7 | 2.54 |
| ESR1 SRX8537722 | MCF-7 Breast | 210 / 10929 (1.9%) | 7163 / 109290 (6.6%) | −106.7 | −104.5 | 0.29 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 566 / 10929 (5.2%) | 12553 / 109290 (11.5%) | −106.7 | −104.4 | 0.45 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 625 / 10929 (5.7%) | 13367 / 109290 (12.2%) | −106.6 | −104.4 | 0.47 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 699 / 10929 (6.4%) | 14374 / 109290 (13.2%) | −106.6 | −104.3 | 0.49 |
| EP300 SRX1012648 | MCF-7 Breast | 95 / 10929 (0.9%) | 5046 / 109290 (4.6%) | −106.3 | −104.1 | 0.19 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 394 / 10929 (3.6%) | 10035 / 109290 (9.2%) | −105.7 | −103.5 | 0.39 |
| ESR1 SRX1469949 | MCF-7 Breast | 121 / 10929 (1.1%) | 5534 / 109290 (5.1%) | −105.6 | −103.4 | 0.22 |
| NR2F2 SRX190293 | MCF-7 Breast | 243 / 10929 (2.2%) | 7661 / 109290 (7.0%) | −105.2 | −103.0 | 0.32 |
| FOXA1 SRX5203303 | MCF-7 Breast | 61 / 10929 (0.6%) | 4285 / 109290 (3.9%) | −105.1 | −102.9 | 0.14 |
| ESR1 SRX10365558 | MCF-7 Breast | 147 / 10929 (1.3%) | 5988 / 109290 (5.5%) | −104.6 | −102.4 | 0.25 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 166 / 10929 (1.5%) | 94 / 109290 (0.1%) | −104.6 | −102.4 | 17.66 |
| NR3C1 SRX2609665 | HASM2 Lung | 256 / 10929 (2.3%) | 7848 / 109290 (7.2%) | −104.5 | −102.3 | 0.33 |
| FOXA1 SRX5323843 | MCF-7 Breast | 105 / 10929 (1.0%) | 5182 / 109290 (4.7%) | −104.3 | −102.1 | 0.20 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 162 / 10929 (1.5%) | 6243 / 109290 (5.7%) | −104.1 | −101.9 | 0.26 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 509 / 10929 (4.7%) | 1479 / 109290 (1.4%) | −104.1 | −101.9 | 3.44 |
| KAT7 DRX234808 | 293 Kidney | 525 / 10929 (4.8%) | 1565 / 109290 (1.4%) | −104.0 | −101.8 | 3.35 |
| NR3C1 SRX2609664 | HASM2 Lung | 329 / 10929 (3.0%) | 8983 / 109290 (8.2%) | −103.9 | −101.7 | 0.37 |
| ESR1 SRX2943589 | MCF-7 Breast | 109 / 10929 (1.0%) | 5239 / 109290 (4.8%) | −103.5 | −101.3 | 0.21 |
| JADE3 DRX234809 | 293 Kidney | 670 / 10929 (6.1%) | 2385 / 109290 (2.2%) | −103.5 | −101.3 | 2.81 |
| FOXA1 SRX028634 | MCF-7 Breast | 106 / 10929 (1.0%) | 5177 / 109290 (4.7%) | −103.4 | −101.2 | 0.20 |
| FOXA1 SRX1787655 | MCF-7 Breast | 106 / 10929 (1.0%) | 5172 / 109290 (4.7%) | −103.2 | −101.0 | 0.20 |
| FOS SRX4192880 | MCF 10A Breast | 424 / 10929 (3.9%) | 10389 / 109290 (9.5%) | −103.2 | −101.0 | 0.41 |
| FOXA1 SRX11222438 | MCF-7 Breast | 113 / 10929 (1.0%) | 5307 / 109290 (4.9%) | −103.1 | −100.9 | 0.21 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 470 / 10929 (4.3%) | 11033 / 109290 (10.1%) | −102.7 | −100.5 | 0.43 |
| ESR1 SRX2881001 | MCF-7 Breast | 117 / 10929 (1.1%) | 5367 / 109290 (4.9%) | −102.6 | −100.4 | 0.22 |
| FOXA1 SRX3931043 | MCF-7 Breast | 242 / 10929 (2.2%) | 7555 / 109290 (6.9%) | −102.4 | −100.3 | 0.32 |
| FOXA1 SRX1787651 | MCF-7 Breast | 123 / 10929 (1.1%) | 5476 / 109290 (5.0%) | −102.3 | −100.2 | 0.22 |
| ESR1 SRX3123829 | MCF-7 Breast | 127 / 10929 (1.2%) | 5530 / 109290 (5.1%) | −101.7 | −99.6 | 0.23 |
| DOT1L DRX411731 | 293 Kidney | 212 / 10929 (1.9%) | 221 / 109290 (0.2%) | −101.6 | −99.5 | 9.59 |
| ESR1 SRX8537723 | MCF-7 Breast | 184 / 10929 (1.7%) | 6554 / 109290 (6.0%) | −101.6 | −99.4 | 0.28 |
| EP300 SRX176885 | MCF-7 Breast | 113 / 10929 (1.0%) | 5259 / 109290 (4.8%) | −101.6 | −99.4 | 0.21 |
| RBFOX2 SRX3322781 | K-562 Blood | 1296 / 10929 (11.9%) | 6604 / 109290 (6.0%) | −101.1 | −99.0 | 1.96 |
| ESR1 SRX1469951 | MCF-7 Breast | 112 / 10929 (1.0%) | 5226 / 109290 (4.8%) | −101.1 | −98.9 | 0.21 |
| ESR1 SRX10365533 | MCF-7 Breast | 102 / 10929 (0.9%) | 5025 / 109290 (4.6%) | −100.9 | −98.7 | 0.20 |
| TEAD1 SRX3401272 | MCF-7 Breast | 182 / 10929 (1.7%) | 6486 / 109290 (5.9%) | −100.7 | −98.5 | 0.28 |
| KAT7 DRX300414 | 293 Kidney | 420 / 10929 (3.8%) | 1065 / 109290 (1.0%) | −100.7 | −98.5 | 3.94 |
| ESR1 SRX11120903 | MCF-7 Breast | 200 / 10929 (1.8%) | 6791 / 109290 (6.2%) | −100.6 | −98.5 | 0.29 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 853 / 10929 (7.8%) | 3566 / 109290 (3.3%) | −100.6 | −98.4 | 2.39 |
| FOXA1 SRX1447317 | MCF-7 Breast | 149 / 10929 (1.4%) | 5897 / 109290 (5.4%) | −100.4 | −98.3 | 0.25 |
| CHD1 SRX186771 | K-562 Blood | 487 / 10929 (4.5%) | 1405 / 109290 (1.3%) | −100.4 | −98.3 | 3.47 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 109 / 10929 (1.0%) | 5145 / 109290 (4.7%) | −100.3 | −98.1 | 0.21 |
| Epitope tags SRX10549777 | K-562 Blood | 1547 / 10929 (14.2%) | 8493 / 109290 (7.8%) | −100.1 | −98.0 | 1.82 |
| FOXA1 SRX3931055 | MCF-7 Breast | 202 / 10929 (1.8%) | 6804 / 109290 (6.2%) | −99.8 | −97.7 | 0.30 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 568 / 10929 (5.2%) | 1851 / 109290 (1.7%) | −99.8 | −97.7 | 3.07 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 588 / 10929 (5.4%) | 12583 / 109290 (11.5%) | −99.8 | −97.7 | 0.47 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 266 / 10929 (2.4%) | 7845 / 109290 (7.2%) | −99.6 | −97.4 | 0.34 |
| ARID1A SRX5089379 | MCF-7 Breast | 241 / 10929 (2.2%) | 7437 / 109290 (6.8%) | −99.5 | −97.4 | 0.32 |
| FOXA1 SRX5203307 | MCF-7 Breast | 56 / 10929 (0.5%) | 4019 / 109290 (3.7%) | −99.4 | −97.2 | 0.14 |
| FOXA1 SRX028635 | MCF-7 Breast | 111 / 10929 (1.0%) | 5153 / 109290 (4.7%) | −99.3 | −97.2 | 0.22 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 147 / 10929 (1.3%) | 68 / 109290 (0.1%) | −99.2 | −97.1 | 21.62 |
| ESR1 SRX1012633 | MCF-7 Breast | 116 / 10929 (1.1%) | 5233 / 109290 (4.8%) | −98.7 | −96.6 | 0.22 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 155 / 10929 (1.4%) | 86 / 109290 (0.1%) | −98.4 | −96.3 | 18.02 |
| EP300 SRX176883 | MCF-7 Breast | 101 / 10929 (0.9%) | 4923 / 109290 (4.5%) | −98.0 | −95.9 | 0.21 |
| AR SRX1067066 | LHSAR Prostate | 521 / 10929 (4.8%) | 11571 / 109290 (10.6%) | −97.9 | −95.8 | 0.45 |
| ESR1 SRX4451213 | MCF-7 Breast | 248 / 10929 (2.3%) | 7493 / 109290 (6.9%) | −97.8 | −95.7 | 0.33 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 782 / 10929 (7.2%) | 3163 / 109290 (2.9%) | −97.8 | −95.6 | 2.47 |
| ESR1 SRX3110723 | MCF-7 Breast | 124 / 10929 (1.1%) | 5354 / 109290 (4.9%) | −97.7 | −95.6 | 0.23 |
| SMARCA2 SRX8119677 | MeT-5A Others | 406 / 10929 (3.7%) | 9916 / 109290 (9.1%) | −97.7 | −95.6 | 0.41 |
| FOXA1 SRX3923517 | MCF-7 Breast | 168 / 10929 (1.5%) | 6149 / 109290 (5.6%) | −97.7 | −95.5 | 0.27 |
| CEBPB SRX150632 | HeLa Uterus | 567 / 10929 (5.2%) | 12186 / 109290 (11.2%) | −97.3 | −95.2 | 0.47 |
| ESR1 SRX1012632 | MCF-7 Breast | 112 / 10929 (1.0%) | 5113 / 109290 (4.7%) | −97.2 | −95.1 | 0.22 |
| NR3C1 SRX2609662 | HASM2 Lung | 295 / 10929 (2.7%) | 8218 / 109290 (7.5%) | −97.2 | −95.1 | 0.36 |
| ESR1 SRX2912055 | MCF-7 Breast | 81 / 10929 (0.7%) | 4497 / 109290 (4.1%) | −97.2 | −95.1 | 0.18 |
| AR SRX1067067 | LHSAR Prostate | 428 / 10929 (3.9%) | 10196 / 109290 (9.3%) | −96.8 | −94.7 | 0.42 |
| ESR1 SRX1995229 | MCF-7 Breast | 242 / 10929 (2.2%) | 7356 / 109290 (6.7%) | −96.6 | −94.5 | 0.33 |
| FOXA1 SRX5203294 | MCF-7 Breast | 59 / 10929 (0.5%) | 4003 / 109290 (3.7%) | −96.4 | −94.3 | 0.15 |
| FOXA1 SRX3931054 | MCF-7 Breast | 233 / 10929 (2.1%) | 7200 / 109290 (6.6%) | −96.3 | −94.2 | 0.32 |
| NR3C1 SRX2609666 | HASM2 Lung | 236 / 10929 (2.2%) | 7246 / 109290 (6.6%) | −96.3 | −94.2 | 0.33 |
| ESR1 SRX330068 | MCF-7 Breast | 106 / 10929 (1.0%) | 4969 / 109290 (4.5%) | −96.3 | −94.2 | 0.21 |
| ESR1 SRX5534831 | MCF-7 Breast | 182 / 10929 (1.7%) | 6342 / 109290 (5.8%) | −96.2 | −94.1 | 0.29 |
| HIF1A SRX8180621 | Peripheral blood mononuclear cells Blood | 146 / 10929 (1.3%) | 73 / 109290 (0.1%) | −96.1 | −94.0 | 20.00 |
| VGLL1 SRX24602130 | BT-20 Breast | 258 / 10929 (2.4%) | 7594 / 109290 (6.9%) | −96.1 | −94.0 | 0.34 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 233 / 10929 (2.1%) | 7190 / 109290 (6.6%) | −96.1 | −94.0 | 0.32 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 432 / 10929 (4.0%) | 1171 / 109290 (1.1%) | −96.0 | −93.9 | 3.69 |
| CHD1 SRX116417 | K-562 Blood | 448 / 10929 (4.1%) | 1254 / 109290 (1.1%) | −95.8 | −93.7 | 3.57 |
| CDK9 SRX7366779 | MCF-7 Breast | 148 / 10929 (1.4%) | 78 / 109290 (0.1%) | −95.7 | −93.6 | 18.97 |
| GATA3 SRX190194 | SK-N-SH Neural | 590 / 10929 (5.4%) | 12429 / 109290 (11.4%) | −95.5 | −93.4 | 0.47 |
| MYC SRX13134693 | 293 Kidney | 844 / 10929 (7.7%) | 3612 / 109290 (3.3%) | −95.0 | −92.9 | 2.34 |
| AR SRX9109110 | MDA-MB-453 Breast | 472 / 10929 (4.3%) | 10754 / 109290 (9.8%) | −94.8 | −92.8 | 0.44 |
| FOXA1 SRX3923516 | MCF-7 Breast | 176 / 10929 (1.6%) | 6194 / 109290 (5.7%) | −94.7 | −92.6 | 0.28 |
| ESR1 SRX5323872 | MCF-7 Breast | 244 / 10929 (2.2%) | 7312 / 109290 (6.7%) | −94.4 | −92.3 | 0.33 |
| JUNB SRX8488088 | SUM 229PE Breast | 495 / 10929 (4.5%) | 11051 / 109290 (10.1%) | −94.0 | −91.9 | 0.45 |
| ESR1 SRX10365534 | MCF-7 Breast | 64 / 10929 (0.6%) | 4045 / 109290 (3.7%) | −93.9 | −91.8 | 0.16 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 203 / 10929 (1.9%) | 6616 / 109290 (6.1%) | −93.7 | −91.7 | 0.31 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 83 / 10929 (0.8%) | 4434 / 109290 (4.1%) | −93.6 | −91.6 | 0.19 |
| FOXA1 SRX3923519 | MCF-7 Breast | 146 / 10929 (1.3%) | 5627 / 109290 (5.1%) | −93.6 | −91.5 | 0.26 |
| ESR1 SRX2513520 | MCF-7 Breast | 151 / 10929 (1.4%) | 5712 / 109290 (5.2%) | −93.4 | −91.4 | 0.26 |
| ESR1 SRX4451212 | MCF-7 Breast | 238 / 10929 (2.2%) | 7182 / 109290 (6.6%) | −93.4 | −91.3 | 0.33 |
| ESR1 SRX2513517 | MCF-7 Breast | 165 / 10929 (1.5%) | 5954 / 109290 (5.4%) | −93.3 | −91.3 | 0.28 |
| ESR1 SRX1995230 | MCF-7 Breast | 208 / 10929 (1.9%) | 6681 / 109290 (6.1%) | −93.2 | −91.1 | 0.31 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 217 / 10929 (2.0%) | 6828 / 109290 (6.2%) | −93.1 | −91.1 | 0.32 |
| SUPT6H SRX15147167 | DLD-1 Digestive tract | 835 / 10929 (7.6%) | 3591 / 109290 (3.3%) | −93.1 | −91.0 | 2.33 |
| GATA3 SRX6712581 | MCF-7 Breast | 208 / 10929 (1.9%) | 6680 / 109290 (6.1%) | −93.0 | −91.0 | 0.31 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 167 / 10929 (1.5%) | 5980 / 109290 (5.5%) | −92.9 | −90.9 | 0.28 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 292 / 10929 (2.7%) | 555 / 109290 (0.5%) | −92.6 | −90.5 | 5.26 |
| ESR1 SRX20282966 | MCF-7 Breast | 79 / 10929 (0.7%) | 4322 / 109290 (4.0%) | −92.6 | −90.5 | 0.18 |
| FOXA1 SRX3923518 | MCF-7 Breast | 169 / 10929 (1.5%) | 6001 / 109290 (5.5%) | −92.6 | −90.5 | 0.28 |
| SETD1A SRX23734380 | MOLM-13 Blood | 671 / 10929 (6.1%) | 2563 / 109290 (2.3%) | −92.5 | −90.4 | 2.62 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 342 / 10929 (3.1%) | 8765 / 109290 (8.0%) | −92.4 | −90.4 | 0.39 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 985 / 10929 (9.0%) | 4616 / 109290 (4.2%) | −92.4 | −90.3 | 2.13 |
| FOXA1 SRX3923515 | MCF-7 Breast | 137 / 10929 (1.3%) | 5429 / 109290 (5.0%) | −92.3 | −90.3 | 0.25 |
| AR SRX9109113 | MDA-MB-453 Breast | 486 / 10929 (4.4%) | 10847 / 109290 (9.9%) | −92.1 | −90.1 | 0.45 |
| ESR1 SRX1469950 | MCF-7 Breast | 84 / 10929 (0.8%) | 4401 / 109290 (4.0%) | −91.8 | −89.7 | 0.19 |
| ESR1 SRX5323873 | MCF-7 Breast | 311 / 10929 (2.8%) | 8262 / 109290 (7.6%) | −91.5 | −89.5 | 0.38 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 240 / 10929 (2.2%) | 7146 / 109290 (6.5%) | −91.5 | −89.4 | 0.34 |
| ESR1 SRX2513521 | MCF-7 Breast | 115 / 10929 (1.1%) | 4987 / 109290 (4.6%) | −91.2 | −89.2 | 0.23 |
| ESR1 SRX5323871 | MCF-7 Breast | 274 / 10929 (2.5%) | 7675 / 109290 (7.0%) | −91.2 | −89.2 | 0.36 |
| NANOG SRX10445309 | Neural crest cells Neural | 139 / 10929 (1.3%) | 5429 / 109290 (5.0%) | −91.2 | −89.1 | 0.26 |
| RELA SRX2207673 | HUVEC Cardiovascular | 906 / 10929 (8.3%) | 16394 / 109290 (15.0%) | −90.9 | −88.9 | 0.55 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 186 / 10929 (1.7%) | 6237 / 109290 (5.7%) | −90.8 | −88.8 | 0.30 |
| CBX3 SRX055348 | HCT 116 Digestive tract | 252 / 10929 (2.3%) | 409 / 109290 (0.4%) | −90.8 | −88.8 | 6.16 |
| ESR1 SRX792933 | LY2 Breast | 205 / 10929 (1.9%) | 6551 / 109290 (6.0%) | −90.8 | −88.7 | 0.31 |
| EP300 SRX1012644 | MCF-7 Breast | 110 / 10929 (1.0%) | 4880 / 109290 (4.5%) | −90.8 | −88.7 | 0.23 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 143 / 10929 (1.3%) | 5479 / 109290 (5.0%) | −90.5 | −88.5 | 0.26 |
| DOT1L DRX059624 | 293 Kidney | 210 / 10929 (1.9%) | 264 / 109290 (0.2%) | −90.3 | −88.2 | 7.95 |
| ZEB1 SRX13298925 | MCF-7 Breast | 154 / 10929 (1.4%) | 5665 / 109290 (5.2%) | −90.2 | −88.2 | 0.27 |
| FOXA1 SRX3923511 | MCF-7 Breast | 88 / 10929 (0.8%) | 4431 / 109290 (4.1%) | −90.1 | −88.0 | 0.20 |
| PAF1 SRX1873455 | SEM Blood | 451 / 10929 (4.1%) | 1338 / 109290 (1.2%) | −89.7 | −87.7 | 3.37 |
| CXXC1 SRX1424886 | SEM Blood | 894 / 10929 (8.2%) | 4051 / 109290 (3.7%) | −89.7 | −87.7 | 2.21 |
| FOXA1 SRX3931033 | MCF-7 Breast | 162 / 10929 (1.5%) | 5788 / 109290 (5.3%) | −89.7 | −87.7 | 0.28 |
| ZEB1 SRX13298924 | MCF-7 Breast | 116 / 10929 (1.1%) | 4961 / 109290 (4.5%) | −89.6 | −87.6 | 0.23 |
| ESR1 SRX1531796 | MCF-7 Breast | 133 / 10929 (1.2%) | 5272 / 109290 (4.8%) | −89.6 | −87.6 | 0.25 |
| FOS SRX150517 | MCF 10A Breast | 459 / 10929 (4.2%) | 10347 / 109290 (9.5%) | −89.2 | −87.2 | 0.44 |
| FOXA2 SRX3230382 | Hep G2 Liver | 358 / 10929 (3.3%) | 8874 / 109290 (8.1%) | −89.0 | −87.0 | 0.40 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 98 / 10929 (0.9%) | 4594 / 109290 (4.2%) | −88.8 | −86.8 | 0.21 |
| DNA-RNA hybrid SRX20083261 | SH-SY5Y Neural | 366 / 10929 (3.3%) | 918 / 109290 (0.8%) | −88.7 | −86.7 | 3.99 |
| ESR1 SRX5089447 | MCF-7 Breast | 113 / 10929 (1.0%) | 4872 / 109290 (4.5%) | −88.7 | −86.7 | 0.23 |
| ESR1 SRX1012628 | MCF-7 Breast | 128 / 10929 (1.2%) | 5144 / 109290 (4.7%) | −88.5 | −86.5 | 0.25 |
| ESR1 SRX5323877 | MCF-7 Breast | 200 / 10929 (1.8%) | 6390 / 109290 (5.8%) | −88.3 | −86.3 | 0.31 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 66 / 10929 (0.6%) | 3929 / 109290 (3.6%) | −88.3 | −86.3 | 0.17 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 230 / 10929 (2.1%) | 6874 / 109290 (6.3%) | −88.3 | −86.3 | 0.33 |
| TFAP2C SRX018833 | MCF-7 Breast | 233 / 10929 (2.1%) | 6924 / 109290 (6.3%) | −88.3 | −86.3 | 0.34 |
| FOXA1 SRX6878603 | LNCAP Prostate | 286 / 10929 (2.6%) | 7748 / 109290 (7.1%) | −87.9 | −85.9 | 0.37 |
| RELA SRX2207672 | HUVEC Cardiovascular | 974 / 10929 (8.9%) | 17100 / 109290 (15.6%) | −87.8 | −85.8 | 0.57 |
| ESR1 SRX3123823 | MCF-7 Breast | 83 / 10929 (0.8%) | 4263 / 109290 (3.9%) | −87.7 | −85.7 | 0.19 |
| FOXA1 SRX3931056 | MCF-7 Breast | 151 / 10929 (1.4%) | 5527 / 109290 (5.1%) | −87.6 | −85.6 | 0.27 |
| TFAP2C SRX128099 | MCF-7 Breast | 234 / 10929 (2.1%) | 6915 / 109290 (6.3%) | −87.6 | −85.6 | 0.34 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 288 / 10929 (2.6%) | 7765 / 109290 (7.1%) | −87.5 | −85.6 | 0.37 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 176 / 10929 (1.6%) | 5955 / 109290 (5.4%) | −87.5 | −85.5 | 0.30 |
| ESR1 SRX1012625 | MCF-7 Breast | 134 / 10929 (1.2%) | 5217 / 109290 (4.8%) | −87.4 | −85.4 | 0.26 |
| FOXA1 SRX15430999 | T-47D Breast | 297 / 10929 (2.7%) | 7893 / 109290 (7.2%) | −87.4 | −85.4 | 0.38 |
| FOXA2 SRX100448 | Hep G2 Liver | 296 / 10929 (2.7%) | 7869 / 109290 (7.2%) | −87.1 | −85.1 | 0.38 |
| FOXA1 SRX3931032 | MCF-7 Breast | 149 / 10929 (1.4%) | 5473 / 109290 (5.0%) | −87.0 | −85.0 | 0.27 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 814 / 10929 (7.4%) | 3577 / 109290 (3.3%) | −86.8 | −84.8 | 2.28 |
| EP300 SRX1012643 | MCF-7 Breast | 91 / 10929 (0.8%) | 4396 / 109290 (4.0%) | −86.8 | −84.8 | 0.21 |
| ESR1 SRX1012631 | MCF-7 Breast | 112 / 10929 (1.0%) | 4793 / 109290 (4.4%) | −86.7 | −84.7 | 0.23 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 80 / 10929 (0.7%) | 4172 / 109290 (3.8%) | −86.7 | −84.7 | 0.19 |
| FOXA1 SRX5323829 | T-47D Breast | 144 / 10929 (1.3%) | 5373 / 109290 (4.9%) | −86.7 | −84.7 | 0.27 |
| AR SRX11149848 | MDA-MB-453 Breast | 168 / 10929 (1.5%) | 5791 / 109290 (5.3%) | −86.6 | −84.6 | 0.29 |
| KMT2A SRX5732680 | MOLM-13 Blood | 835 / 10929 (7.6%) | 3722 / 109290 (3.4%) | −86.6 | −84.6 | 2.24 |
| ESR1 SRX1012630 | MCF-7 Breast | 96 / 10929 (0.9%) | 4486 / 109290 (4.1%) | −86.6 | −84.6 | 0.21 |
| ARID1A SRX5089391 | MCF-7 Breast | 147 / 10929 (1.3%) | 5423 / 109290 (5.0%) | −86.5 | −84.5 | 0.27 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 172 / 10929 (1.6%) | 5857 / 109290 (5.4%) | −86.5 | −84.5 | 0.29 |
| FOXA1 SRX1787654 | MCF-7 Breast | 92 / 10929 (0.8%) | 4403 / 109290 (4.0%) | −86.4 | −84.4 | 0.21 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 401 / 10929 (3.7%) | 9402 / 109290 (8.6%) | −86.4 | −84.4 | 0.43 |
| AR SRX15946405 | MDA-MB-453 Breast | 168 / 10929 (1.5%) | 5783 / 109290 (5.3%) | −86.3 | −84.4 | 0.29 |
| ARID1A SRX5089388 | MCF-7 Breast | 133 / 10929 (1.2%) | 5162 / 109290 (4.7%) | −86.1 | −84.1 | 0.26 |
| ESR1 SRX3123830 | MCF-7 Breast | 66 / 10929 (0.6%) | 3869 / 109290 (3.5%) | −86.1 | −84.1 | 0.17 |
| NR3C1 SRX19024866 | MCF-7 Breast | 86 / 10929 (0.8%) | 4272 / 109290 (3.9%) | −86.0 | −84.0 | 0.20 |
| ESR1 SRX3110720 | MCF-7 Breast | 105 / 10929 (1.0%) | 4641 / 109290 (4.2%) | −85.9 | −83.9 | 0.23 |
| NR3C1 SRX8520802 | HCC1187 Breast | 196 / 10929 (1.8%) | 6236 / 109290 (5.7%) | −85.8 | −83.9 | 0.31 |
| GATA2 SRX16314543 | Trophoblast stem cells Placenta | 240 / 10929 (2.2%) | 6949 / 109290 (6.4%) | −85.8 | −83.8 | 0.35 |
| WWTR1 SRX10119367 | MCF 10A Breast | 315 / 10929 (2.9%) | 8107 / 109290 (7.4%) | −85.8 | −83.8 | 0.39 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 369 / 10929 (3.4%) | 8906 / 109290 (8.1%) | −85.6 | −83.6 | 0.41 |
| ARID1A SRX5089385 | MCF-7 Breast | 202 / 10929 (1.8%) | 6327 / 109290 (5.8%) | −85.6 | −83.6 | 0.32 |
| FOXA1 SRX5323845 | MCF-7 Breast | 91 / 10929 (0.8%) | 4354 / 109290 (4.0%) | −85.4 | −83.5 | 0.21 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 904 / 10929 (8.3%) | 16096 / 109290 (14.7%) | −85.3 | −83.3 | 0.56 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 266 / 10929 (2.4%) | 7340 / 109290 (6.7%) | −85.2 | −83.3 | 0.36 |
| FOXA1 SRX1961158 | T-47D Breast | 266 / 10929 (2.4%) | 7333 / 109290 (6.7%) | −85.1 | −83.1 | 0.36 |
| PAF1 SRX15147186 | DLD-1 Digestive tract | 502 / 10929 (4.6%) | 1677 / 109290 (1.5%) | −85.0 | −83.1 | 2.99 |
| FOXA1 SRX1961157 | T-47D Breast | 290 / 10929 (2.7%) | 7701 / 109290 (7.0%) | −85.0 | −83.0 | 0.38 |
| FOXA1 SRX1447316 | MCF-7 Breast | 110 / 10929 (1.0%) | 4702 / 109290 (4.3%) | −84.9 | −83.0 | 0.23 |
| ESR1 SRX5323878 | MCF-7 Breast | 266 / 10929 (2.4%) | 7322 / 109290 (6.7%) | −84.8 | −82.9 | 0.36 |
| ESR1 SRX20282945 | MCF-7 Breast | 61 / 10929 (0.6%) | 3725 / 109290 (3.4%) | −84.8 | −82.9 | 0.16 |
| ZEB1 SRX13298923 | MCF-7 Breast | 110 / 10929 (1.0%) | 4699 / 109290 (4.3%) | −84.7 | −82.8 | 0.23 |
| FOXA1 SRX5323830 | T-47D Breast | 156 / 10929 (1.4%) | 5523 / 109290 (5.1%) | −84.7 | −82.7 | 0.28 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 263 / 10929 (2.4%) | 7268 / 109290 (6.7%) | −84.6 | −82.6 | 0.36 |
| HMG20A SRX2630163 | Hep G2 Liver | 149 / 10929 (1.4%) | 5394 / 109290 (4.9%) | −84.6 | −82.6 | 0.28 |
| ESR1 SRX20282967 | MCF-7 Breast | 75 / 10929 (0.7%) | 4009 / 109290 (3.7%) | −84.5 | −82.6 | 0.19 |
| TET2 SRX8617001 | MCF-7 Breast | 172 / 10929 (1.6%) | 5777 / 109290 (5.3%) | −84.1 | −82.1 | 0.30 |
| ESR1 SRX176856 | MCF-7 Breast | 86 / 10929 (0.8%) | 4214 / 109290 (3.9%) | −84.0 | −82.0 | 0.20 |
| RBM22 SRX4708083 | K-562 Blood | 575 / 10929 (5.3%) | 2116 / 109290 (1.9%) | −84.0 | −82.0 | 2.72 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1199 / 10929 (11.0%) | 6354 / 109290 (5.8%) | −83.9 | −82.0 | 1.89 |
| TCF12 SRX190356 | SK-N-SH Neural | 711 / 10929 (6.5%) | 13547 / 109290 (12.4%) | −83.9 | −82.0 | 0.52 |
| ESR1 SRX5089450 | MCF-7 Breast | 143 / 10929 (1.3%) | 5266 / 109290 (4.8%) | −83.8 | −81.9 | 0.27 |
| EP300 SRX2671813 | Fibroblasts Others | 232 / 10929 (2.1%) | 6752 / 109290 (6.2%) | −83.8 | −81.9 | 0.34 |
| ESR1 SRX5534832 | MCF-7 Breast | 243 / 10929 (2.2%) | 6922 / 109290 (6.3%) | −83.6 | −81.7 | 0.35 |
| ESR1 SRX3554403 | MDA-MB-134-VI Breast | 117 / 10929 (1.1%) | 4792 / 109290 (4.4%) | −83.6 | −81.7 | 0.24 |
| SETD1A SRX23734394 | MOLM-13 Blood | 638 / 10929 (5.8%) | 2511 / 109290 (2.3%) | −83.4 | −81.5 | 2.54 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 260 / 10929 (2.4%) | 7176 / 109290 (6.6%) | −83.4 | −81.4 | 0.36 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 351 / 10929 (3.2%) | 897 / 109290 (0.8%) | −83.4 | −81.4 | 3.91 |
| VGLL1 SRX18013277 | FULVR Breast | 115 / 10929 (1.1%) | 4749 / 109290 (4.3%) | −83.3 | −81.4 | 0.24 |
| CEBPB SRX190345 | MCF-7 Breast | 216 / 10929 (2.0%) | 6475 / 109290 (5.9%) | −83.3 | −81.4 | 0.33 |
| ESR1 SRX5287697 | MCF-7 Breast | 94 / 10929 (0.9%) | 4350 / 109290 (4.0%) | −83.3 | −81.4 | 0.22 |
| FOS SRX4192879 | MCF 10A Breast | 324 / 10929 (3.0%) | 8147 / 109290 (7.5%) | −83.2 | −81.3 | 0.40 |
| KMT2B DRX059615 | HB1119 Blood | 539 / 10929 (4.9%) | 1918 / 109290 (1.8%) | −83.0 | −81.1 | 2.81 |
| CEBPA SRX2630241 | Hep G2 Liver | 332 / 10929 (3.0%) | 8258 / 109290 (7.6%) | −83.0 | −81.1 | 0.40 |
| ESR1 SRX2513518 | MCF-7 Breast | 127 / 10929 (1.2%) | 4955 / 109290 (4.5%) | −83.0 | −81.0 | 0.26 |
| FOXA1 SRX100477 | Hep G2 Liver | 312 / 10929 (2.9%) | 7955 / 109290 (7.3%) | −82.9 | −81.0 | 0.39 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 236 / 10929 (2.2%) | 6782 / 109290 (6.2%) | −82.9 | −81.0 | 0.35 |
| FOXA1 SRX100506 | Hep G2 Liver | 365 / 10929 (3.3%) | 8740 / 109290 (8.0%) | −82.8 | −80.9 | 0.42 |
| KDM4C SRX424010 | KYSE-150 Digestive tract | 752 / 10929 (6.9%) | 3251 / 109290 (3.0%) | −82.7 | −80.8 | 2.31 |
| EP300 SRX2194266 | SUM 159PT Breast | 468 / 10929 (4.3%) | 10209 / 109290 (9.3%) | −82.7 | −80.8 | 0.46 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 666 / 10929 (6.1%) | 12896 / 109290 (11.8%) | −82.7 | −80.8 | 0.52 |
| FOS SRX150476 | MCF 10A Breast | 483 / 10929 (4.4%) | 10416 / 109290 (9.5%) | −82.7 | −80.7 | 0.46 |
| PGR SRX3990986 | T-47D Breast | 235 / 10929 (2.2%) | 6755 / 109290 (6.2%) | −82.6 | −80.7 | 0.35 |
| NR3C1 SRX19024870 | MCF-7 Breast | 86 / 10929 (0.8%) | 4174 / 109290 (3.8%) | −82.6 | −80.7 | 0.21 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 474 / 10929 (4.3%) | 10288 / 109290 (9.4%) | −82.6 | −80.6 | 0.46 |
| FOXA1 SRX1161203 | T-47D Breast | 195 / 10929 (1.8%) | 6109 / 109290 (5.6%) | −82.5 | −80.6 | 0.32 |
| RTF1 SRX15147196 | DLD-1 Digestive tract | 413 / 10929 (3.8%) | 1221 / 109290 (1.1%) | −82.5 | −80.6 | 3.38 |
| FOXA1 SRX3923510 | MCF-7 Breast | 98 / 10929 (0.9%) | 4400 / 109290 (4.0%) | −82.5 | −80.6 | 0.22 |
| FOXA1 SRX5323846 | MCF-7 Breast | 99 / 10929 (0.9%) | 4414 / 109290 (4.0%) | −82.2 | −80.3 | 0.22 |
| Epitope tags SRX8080552 | Mammary gland ductal carcinoma Breast | 130 / 10929 (1.2%) | 4979 / 109290 (4.6%) | −82.1 | −80.2 | 0.26 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 258 / 10929 (2.4%) | 7098 / 109290 (6.5%) | −82.1 | −80.2 | 0.36 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 74 / 10929 (0.7%) | 3915 / 109290 (3.6%) | −82.0 | −80.1 | 0.19 |
| NUP98 SRX20440536 | Keratinocytes Epidermis | 303 / 10929 (2.8%) | 684 / 109290 (0.6%) | −82.0 | −80.1 | 4.43 |
| ESR1 SRX968963 | MCF-7 Breast | 107 / 10929 (1.0%) | 4554 / 109290 (4.2%) | −81.9 | −80.0 | 0.23 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 229 / 10929 (2.1%) | 6635 / 109290 (6.1%) | −81.8 | −79.9 | 0.35 |
| AHR SRX20282969 | MCF-7 Breast | 127 / 10929 (1.2%) | 4919 / 109290 (4.5%) | −81.8 | −79.9 | 0.26 |
| NR3C1 SRX17639412 | A549 Lung | 310 / 10929 (2.8%) | 7881 / 109290 (7.2%) | −81.7 | −79.8 | 0.39 |
| ESR1 SRX2922232 | SUM 44PE Breast | 109 / 10929 (1.0%) | 4586 / 109290 (4.2%) | −81.7 | −79.8 | 0.24 |
| AR SRX9469987 | LAPC-4 Prostate | 127 / 10929 (1.2%) | 4911 / 109290 (4.5%) | −81.7 | −79.8 | 0.26 |
| ESR1 SRX5323874 | MCF-7 Breast | 157 / 10929 (1.4%) | 5433 / 109290 (5.0%) | −81.5 | −79.6 | 0.29 |
| FOXA2 SRX11650947 | hESC derived pancreatic cells Pluripotent stem cell | 185 / 10929 (1.7%) | 5906 / 109290 (5.4%) | −81.5 | −79.6 | 0.31 |
| FOXA1 SRX190282 | A549 Lung | 196 / 10929 (1.8%) | 6085 / 109290 (5.6%) | −81.4 | −79.5 | 0.32 |
| CDK9 SRX7366780 | MCF-7 Breast | 126 / 10929 (1.2%) | 67 / 109290 (0.1%) | −81.3 | −79.4 | 18.81 |
| GFP SRX12567758 | MRC-5 Lung | 913 / 10929 (8.4%) | 4379 / 109290 (4.0%) | −80.9 | −79.0 | 2.08 |
| ESR1 SRX8537719 | SUM 44PE Breast | 168 / 10929 (1.5%) | 5600 / 109290 (5.1%) | −80.9 | −79.0 | 0.30 |
| ESR1 SRX2513519 | MCF-7 Breast | 149 / 10929 (1.4%) | 5277 / 109290 (4.8%) | −80.8 | −78.9 | 0.28 |
| FOXA1 SRX6878604 | LNCAP Prostate | 222 / 10929 (2.0%) | 6481 / 109290 (5.9%) | −80.7 | −78.8 | 0.34 |
| NCOA3 SRX4663589 | MCF-7 Breast | 77 / 10929 (0.7%) | 3933 / 109290 (3.6%) | −80.6 | −78.7 | 0.20 |
| NR3C1 SRX2609659 | HASM2 Lung | 321 / 10929 (2.9%) | 8003 / 109290 (7.3%) | −80.5 | −78.6 | 0.40 |
| GATA3 SRX100559 | T-47D Breast | 308 / 10929 (2.8%) | 7803 / 109290 (7.1%) | −80.5 | −78.6 | 0.39 |
| CTNNB1 SRX833403 | hESC H1 Pluripotent stem cell | 81 / 10929 (0.7%) | 4011 / 109290 (3.7%) | −80.4 | −78.5 | 0.20 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 315 / 10929 (2.9%) | 7903 / 109290 (7.2%) | −80.3 | −78.4 | 0.40 |
| LARP7 SRX2198835 | HeLa Uterus | 1285 / 10929 (11.8%) | 7100 / 109290 (6.5%) | −80.3 | −78.4 | 1.81 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 886 / 10929 (8.1%) | 15623 / 109290 (14.3%) | −80.2 | −78.4 | 0.57 |
| GATA3 SRX5457550 | MCF-7 Breast | 318 / 10929 (2.9%) | 7947 / 109290 (7.3%) | −80.2 | −78.3 | 0.40 |
| ESR1 SRX4451214 | MCF-7 Breast | 245 / 10929 (2.2%) | 6827 / 109290 (6.2%) | −80.2 | −78.3 | 0.36 |
| FOXA1 SRX190181 | A549 Lung | 204 / 10929 (1.9%) | 6174 / 109290 (5.6%) | −80.2 | −78.3 | 0.33 |
| FOXA2 SRX11650943 | hESC derived pancreatic cells Pluripotent stem cell | 169 / 10929 (1.5%) | 5595 / 109290 (5.1%) | −80.1 | −78.2 | 0.30 |
| SFPQ SRX593748 | MCF-7 Breast | 1742 / 10929 (15.9%) | 10682 / 109290 (9.8%) | −79.8 | −77.9 | 1.63 |
| NR3C1 SRX19024880 | MCF-7 Breast | 69 / 10929 (0.6%) | 3747 / 109290 (3.4%) | −79.7 | −77.8 | 0.18 |
| PROX1 SRX3230397 | Hep G2 Liver | 205 / 10929 (1.9%) | 6172 / 109290 (5.6%) | −79.7 | −77.8 | 0.33 |
| GFP SRX6949256 | HeLa Uterus | 304 / 10929 (2.8%) | 7714 / 109290 (7.1%) | −79.6 | −77.8 | 0.39 |
| NR3C1 SRX10977357 | A549 Lung | 177 / 10929 (1.6%) | 5713 / 109290 (5.2%) | −79.6 | −77.7 | 0.31 |
| Epitope tags SRX392690 | T3M-1 Cl-10 Others | 123 / 10929 (1.1%) | 65 / 109290 (0.1%) | −79.6 | −77.7 | 18.92 |
| KMT2B DRX059614 | HB1119 Blood | 534 / 10929 (4.9%) | 1942 / 109290 (1.8%) | −79.5 | −77.6 | 2.75 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 876 / 10929 (8.0%) | 15460 / 109290 (14.1%) | −79.5 | −77.6 | 0.57 |
| NR3C1 SRX10976921 | A549 Lung | 199 / 10929 (1.8%) | 6070 / 109290 (5.6%) | −79.5 | −77.6 | 0.33 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 1146 / 10929 (10.5%) | 6090 / 109290 (5.6%) | −79.4 | −77.5 | 1.88 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 119 / 10929 (1.1%) | 4699 / 109290 (4.3%) | −79.4 | −77.5 | 0.25 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 404 / 10929 (3.7%) | 9165 / 109290 (8.4%) | −79.3 | −77.5 | 0.44 |
| MEN1 SRX14030471 | MV-4-11 Blood | 595 / 10929 (5.4%) | 2315 / 109290 (2.1%) | −79.2 | −77.4 | 2.57 |
| FOXA1 SRX3931031 | MCF-7 Breast | 130 / 10929 (1.2%) | 4889 / 109290 (4.5%) | −79.2 | −77.3 | 0.27 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 285 / 10929 (2.6%) | 7406 / 109290 (6.8%) | −79.1 | −77.3 | 0.38 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 209 / 10929 (1.9%) | 6214 / 109290 (5.7%) | −78.9 | −77.1 | 0.34 |
| KDM6A SRX15826236 | MCF-7 Breast | 88 / 10929 (0.8%) | 4101 / 109290 (3.8%) | −78.9 | −77.0 | 0.21 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 286 / 10929 (2.6%) | 7414 / 109290 (6.8%) | −78.9 | −77.0 | 0.39 |
| CDK9 SRX7366782 | MCF-7 Breast | 119 / 10929 (1.1%) | 59 / 109290 (0.1%) | −78.7 | −76.8 | 20.17 |
| ESR1 SRX3080213 | MCF-7 Breast | 67 / 10929 (0.6%) | 3675 / 109290 (3.4%) | −78.6 | −76.7 | 0.18 |
| HDAC1 SRX20517420 | Keratinocytes Epidermis | 1003 / 10929 (9.2%) | 5075 / 109290 (4.6%) | −78.4 | −76.5 | 1.98 |
| CHD7 SRX3581504 | iPS cells Pluripotent stem cell | 60 / 10929 (0.5%) | 3522 / 109290 (3.2%) | −78.3 | −76.5 | 0.17 |
| GATA2 SRX16314544 | Trophoblast stem cells Placenta | 175 / 10929 (1.6%) | 5631 / 109290 (5.2%) | −78.3 | −76.4 | 0.31 |
| STAT3 SRX2020842 | HCC70 Breast | 490 / 10929 (4.5%) | 10328 / 109290 (9.5%) | −78.3 | −76.4 | 0.47 |
| NCOA3 SRX10365550 | MCF-7 Breast | 20 / 10929 (0.2%) | 2576 / 109290 (2.4%) | −78.3 | −76.4 | 0.08 |
| JUN SRX4192884 | MCF 10A Breast | 247 / 10929 (2.3%) | 6792 / 109290 (6.2%) | −78.2 | −76.4 | 0.36 |
| ESR1 SRX8537718 | SUM 44PE Breast | 165 / 10929 (1.5%) | 5459 / 109290 (5.0%) | −78.2 | −76.3 | 0.30 |
| ESR1 SRX9719167 | MCF-7 Breast | 126 / 10929 (1.2%) | 4782 / 109290 (4.4%) | −78.1 | −76.2 | 0.26 |
| EP300 SRX1012649 | MCF-7 Breast | 89 / 10929 (0.8%) | 4096 / 109290 (3.7%) | −78.0 | −76.2 | 0.22 |
| NR3C1 SRX2609667 | HASM2 Lung | 278 / 10929 (2.5%) | 7249 / 109290 (6.6%) | −77.8 | −76.0 | 0.38 |
| FOXA1 SRX1161205 | T-47D Breast | 149 / 10929 (1.4%) | 5175 / 109290 (4.7%) | −77.7 | −75.9 | 0.29 |
| KMT2A SRX2323891 | 293 Kidney | 574 / 10929 (5.3%) | 2211 / 109290 (2.0%) | −77.7 | −75.9 | 2.60 |
| ARID1A SRX5089382 | MCF-7 Breast | 202 / 10929 (1.8%) | 6057 / 109290 (5.5%) | −77.7 | −75.8 | 0.33 |
| ESR1 SRX5323876 | MCF-7 Breast | 147 / 10929 (1.3%) | 5139 / 109290 (4.7%) | −77.6 | −75.8 | 0.29 |
| GATA1 SRX4172742 | HCT 116 Digestive tract | 877 / 10929 (8.0%) | 4206 / 109290 (3.8%) | −77.5 | −75.7 | 2.09 |
| MAU2 SRX15710550 | Fibroblasts Others | 463 / 10929 (4.2%) | 9917 / 109290 (9.1%) | −77.4 | −75.6 | 0.47 |
| WWTR1 SRX10119378 | MCF 10A Breast | 309 / 10929 (2.8%) | 7699 / 109290 (7.0%) | −77.3 | −75.5 | 0.40 |
| SUPT6H SRX15147169 | DLD-1 Digestive tract | 665 / 10929 (6.1%) | 2792 / 109290 (2.6%) | −77.3 | −75.4 | 2.38 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 195 / 10929 (1.8%) | 5924 / 109290 (5.4%) | −77.2 | −75.4 | 0.33 |
| ESR1 SRX176858 | MCF-7 Breast | 94 / 10929 (0.9%) | 4163 / 109290 (3.8%) | −77.1 | −75.3 | 0.23 |
| FOXA1 SRX3923513 | MCF-7 Breast | 83 / 10929 (0.8%) | 3952 / 109290 (3.6%) | −77.1 | −75.3 | 0.21 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 372 / 10929 (3.4%) | 8617 / 109290 (7.9%) | −77.1 | −75.3 | 0.43 |
| JUNB SRX8488073 | SUM 229PE Breast | 525 / 10929 (4.8%) | 10758 / 109290 (9.8%) | −77.1 | −75.2 | 0.49 |
| FOXA1 SRX3923509 | MCF-7 Breast | 80 / 10929 (0.7%) | 3883 / 109290 (3.6%) | −76.8 | −75.0 | 0.21 |
| TAF3 SRX217738 | HCT 116 Digestive tract | 749 / 10929 (6.9%) | 3352 / 109290 (3.1%) | −76.8 | −75.0 | 2.23 |
| TRPS1 SRX3401273 | MCF-7 Breast | 100 / 10929 (0.9%) | 4268 / 109290 (3.9%) | −76.8 | −74.9 | 0.23 |
| ESR1 SRX1585242 | MCF-7 Breast | 108 / 10929 (1.0%) | 4408 / 109290 (4.0%) | −76.6 | −74.8 | 0.25 |
| ESR1 SRX2881004 | MCF-7 Breast | 69 / 10929 (0.6%) | 3656 / 109290 (3.3%) | −76.6 | −74.8 | 0.19 |
| GATAD2A SRX2636506 | Hep G2 Liver | 360 / 10929 (3.3%) | 8413 / 109290 (7.7%) | −76.4 | −74.6 | 0.43 |
| ARID5B SRX3230377 | Hep G2 Liver | 678 / 10929 (6.2%) | 12766 / 109290 (11.7%) | −76.4 | −74.5 | 0.53 |
| AR SRX1067068 | LHSAR Prostate | 344 / 10929 (3.1%) | 8177 / 109290 (7.5%) | −76.3 | −74.5 | 0.42 |
| FOXA1 SRX2642368 | VCaP Prostate | 344 / 10929 (3.1%) | 8179 / 109290 (7.5%) | −76.3 | −74.5 | 0.42 |
| TET2 SRX8617003 | MCF-7 Breast | 90 / 10929 (0.8%) | 4064 / 109290 (3.7%) | −76.3 | −74.5 | 0.22 |
| NR3C1 SRX10977372 | A549 Lung | 170 / 10929 (1.6%) | 5479 / 109290 (5.0%) | −76.2 | −74.4 | 0.31 |
| MEN1 SRX14030481 | MV-4-11 Blood | 534 / 10929 (4.9%) | 1992 / 109290 (1.8%) | −76.2 | −74.4 | 2.68 |
| FOXA2 SRX11650945 | hESC derived pancreatic cells Pluripotent stem cell | 183 / 10929 (1.7%) | 5693 / 109290 (5.2%) | −76.2 | −74.4 | 0.32 |
| ESR1 SRX3080214 | MCF-7 Breast | 64 / 10929 (0.6%) | 3541 / 109290 (3.2%) | −76.2 | −74.4 | 0.18 |
| CHD1 SRX116454 | hESC H1 Pluripotent stem cell | 483 / 10929 (4.4%) | 1689 / 109290 (1.5%) | −76.2 | −74.4 | 2.86 |
| FOXA1 SRX3923512 | MCF-7 Breast | 78 / 10929 (0.7%) | 3826 / 109290 (3.5%) | −76.1 | −74.3 | 0.20 |
Showing first 500 of 21078 rows.